Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
Dow Jones Industrial Average
NASDAQ Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries
AstraZeneca PLC - American Depositary Shares
(NY:
AZN
)
184.48
-4.45 (-2.36%)
Streaming Delayed Price
Updated: 1:52 PM EDT, Mar 20, 2026
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
1,379,814
Open
188.14
Bid (Size)
184.39 (100)
Ask (Size)
184.57 (100)
Prev. Close
188.93
Today's Range
184.16 - 188.40
52wk Range
183.63 - 212.71
Shares Outstanding
N/A
Dividend Yield
0.50%
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
The Great Unbundling: How AI’s Insatiable Hunger is Driving a Corporate Divestiture Gold Rush
March 18, 2026
As of March 18, 2026, the corporate landscape has undergone a radical transformation. The era of the sprawling global conglomerate, once the gold standard of industrial stability, is rapidly giving way...
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Could This International ETF Be One of the Best Investments of 2026?
↗
March 14, 2026
International stocks look attractively valued in an expensive market environment.
Via
The Motley Fool
Topics
ETFs
Performance
YTD
-2.1%
-2.1%
1 Month
-11.9%
-11.9%
3 Month
-2.1%
-2.1%
6 Month
-2.1%
-2.1%
1 Year
-2.1%
-2.1%
More News
Read More
The 'Sentiment Trap': Why Beating Earnings Is No Longer Enough in the Age of AI Sentiment Analysis
March 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Regulatory Compliance
The Billion-Dollar Divide: How "Megadeals" Are Defining a K-Shaped M&A Market in 2026
March 11, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Energy
Pfizer (PFE) 2026 Research Feature: The High-Stakes Pivot to Oncology and Obesity
March 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Lawsuit
AstraZeneca and Joshua Jackson partner to encourage fans to Get Body Checked Against Cancer
March 10, 2026
From
AstraZeneca
Via
Business Wire
ENHERTU® (fam-trastuzumab deruxtecan-nxki) granted Priority Review in the US as post-neoadjuvant treatment for patients with HER2-positive early breast cancer
March 09, 2026
From
AstraZeneca
Via
Business Wire
The Great Rotation: Why Global Capital is Deserting US Tech for International Value in 2026
March 05, 2026
Via
MarketMinute
Topics
Artificial Intelligence
ETFs
Economy
Compugen (CGEN) Q4 2025 Earnings Call Transcript
↗
March 02, 2026
Via
The Motley Fool
Topics
Earnings
As Investors Flee U.S. Equities, This Global ETF Is Outperforming
↗
March 02, 2026
Via
MarketBeat
Topics
ETFs
After a Near 50% Drop, Tempus AI Could Be Ripe for a Rebound
↗
February 27, 2026
Via
MarketBeat
Topics
Artificial Intelligence
Pfizer Secures Full FDA Approval for BRAFTOVI in First-Line Colorectal Cancer, Bolstering Oncology Growth Strategy
February 26, 2026
Via
MarketMinute
Topics
Economy
Intellectual Property
AstraZeneca’s Strategic Leap: Pharmaceutical Giant Completes Historic Move to the New York Stock Exchange
February 26, 2026
Via
MarketMinute
Topics
ETFs
Eli Lilly Bolsters Genetic Medicine Portfolio with $2.4 Billion Acquisition of Orna Therapeutics
February 25, 2026
Via
MarketMinute
Topics
Intellectual Property
CALQUENCE® plus venetoclax approved in the US as first all-oral, fixed-duration combination for patients with chronic lymphocytic leukemia in the 1st-line setting
February 20, 2026
From
AstraZeneca
Via
Business Wire
ASCO GU 2026: Merck and Protara Poised to Disrupt Bladder and Kidney Cancer Standards
February 16, 2026
Via
MarketMinute
Topics
Intellectual Property
Buy 2 Vanguard Index Funds to Beat the S&P 500 in the Next Decade, According to Wall Street Analysts
↗
February 16, 2026
Via
The Motley Fool
Topics
ETFs
Stocks
The Great 2026 Divergence: Tech Titans Rise on AI Execution While Healthcare Reaps a Regulatory Whirlwind
February 13, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
Intellectual Property
Positive and clinically meaningful results from the Phase III KALOS and LOGOS trials for BREZTRI in patients with uncontrolled asthma published in The Lancet Respiratory Medicine
February 13, 2026
From
AstraZeneca
Via
Business Wire
A Closer Look at Healthcare Sector Earnings: AZN vs. EW vs. ZBH
↗
February 12, 2026
Via
MarketBeat
Alnylam Pharmaceuticals (ALNY): The RNAi Pioneer’s 2026 Breakout and the Battle for Cardiovascular Dominance
February 12, 2026
Via
Finterra
Topics
Economy
Intellectual Property
The Great Rebound: 2026 Becomes the Year of the Strategic Mega-Deal as M&A Activity Surges
February 11, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Economy
AstraZeneca awards $3.4 million for programs to improve access to healthcare for patients across the US
February 11, 2026
From
AstraZeneca
Via
Business Wire
AstraZeneca Signals a New Era in Obesity Care: Earnings Report Teases Oral GLP-1 Powerhouse
February 10, 2026
Via
MarketMinute
Topics
Artificial Intelligence
Earnings
Economy
Gilead’s Second Act: A 2026 Deep Dive into the Transition from Virology to Oncology Powerhouse
February 10, 2026
Via
Finterra
Topics
Economy
Intellectual Property
Frequently Asked Questions
Is AstraZeneca PLC - American Depositary Shares publicly traded?
Yes, AstraZeneca PLC - American Depositary Shares is publicly traded.
What exchange does AstraZeneca PLC - American Depositary Shares trade on?
AstraZeneca PLC - American Depositary Shares trades on the New York Stock Exchange
What is the ticker symbol for AstraZeneca PLC - American Depositary Shares?
The ticker symbol for AstraZeneca PLC - American Depositary Shares is AZN on the New York Stock Exchange
What is the current price of AstraZeneca PLC - American Depositary Shares?
The current price of AstraZeneca PLC - American Depositary Shares is 184.48
When was AstraZeneca PLC - American Depositary Shares last traded?
The last trade of AstraZeneca PLC - American Depositary Shares was at 03/20/26 01:52 PM ET
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the
Privacy Policy
and
Terms Of Service
.
© 2025 FinancialContent. All rights reserved.